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Evaluation of the Anti-microbial Activities of the Extracts of the Leaf and Stem Bark 
of Alstonia congensis on Some Human Pathogenic Bacteria 
 
Abstract: 
Background: Prohibitive cost of treatments in developing countries is a challenge under 
poor economic circumstances. Side effects of several synthetic drugs and the 
development of resistance to currently used antibiotics for infectious diseases have led to 
increased emphasis on the use of plant materials as a source of medicine for a wide 
variety of human ailments. In addition to this and the high level of poverty in developing 
countries, the use of alternate medicine to cure some diseases is now encouraged in 
Nigeria to serve as an alternative for orthodox medicine. In this study, phytochemical 
screening and the anti-microbial capability of parts of a popular African medicinal plant, 
Alstonia congensis, was evaluated. Materials and Methods: The effects of the plant parts 
extracts on some human pathogenic bacteria viz; Escherichia coli, Neisseria gonorrhoeae, 
Staphylococcus aureus, Salmonella typhi, Proteus mirabilis, Pseudomonas aeruginosa and 
Klebsiella pneumoniae were examined in vitro using hexane, ethanol, petroleum ether and 
water (aqueous) as extractants and at concentrations of 120, 80, 60, 48 and 40mg/ml 
respectively. Agar well diffusion technique was employed throughout the 
experimentation. It was discovered that petroleum ether and ethanolic extracts of the 
leaves and stem bark showed appreciable inhibitory effects on the test bacteria (the leaf 
extracts were more potent than the stem bark extracts). The Minimum Inhibitory 
Concentration (MIC) of each of the extracts was determined. Results: Petroleum ether as 
well as ethanolic extracts of the leaves was effective on all the bacterial isolates at MIC 
between 40 mg/ml and 60mg/ml respectively while the aqueous extract of the leaf was 
slightly effective on E. coli, N. gonorrhoeae, Staphylococcus aureus, S. typhi and P. mirabilis at 
MIC between 60mg/ml and 80mg/ml. It was only the hexane extract of the leaf that was 
not effective against any of the test bacteria. The ethanolic and petroleum ether extracts 
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of the stem bark was effective against Staphlococcus aureus, S. typhi, P. mirabilis and 
Klebsiella pneumoniae at MIC between 40mg/ml and 60mg/ml while ethanolic extract of 
the leaf was not effective against E. coli. Likewise, the hexane extract of the stem bark was 
not effective against Neisseria gonorrhoeae. The aqueous extract of the stem bark showed 
no effect against Escherichia coli but slightly effective against other isolates at MIC of 
80mg/ml for Neisseria gonorrhoeae, Staphylococcus aureus, Salmonella typhi, Proteus mirabilis, 
Pseudomonas aeruginosa and at120mg/ml for Klebsiella pneumoniae. Hexane extract of the 
stem bark did not have any effect against Neisseria gonorrhoeae, Staphylococcus aureus, 
Salmonella typhi and Pseudomonas aeruginosa but very effective against Escherichia coli and 
Proteus mirabilis at MIC of 60mg/ml but at 40mg/ml for Klebsiella pneumoniae. Petroleum 
ether and ethanolic extracts showed much wider zones of inhibition on each of the test 
bacteria and therefore regarded as the best solvents for extraction. The result of the 
Standard Antibiotics Disc (SAD) showed that E.coli was inhibited by Ofloxacin (21mm), 
Klebsiella pneumoniae (22mm), P.aeruginosa (24mm), N. gonorrhoeae (25mm), S. typhi and P. 
mirabilis (30mm). E. coli and N. gonorrhoeae was inhibited by Nalidixic acid (22mm), S. 
typhi and P. aeruginosa (20mm) and Klebsiella pneumoniae (10mm). Also, Gentamycin 
inhibited E.coli (9mm), N. gonorrhoeae (13mm), S. typhi (12mm), P. mirabilis (13mm ) and 
P.aeruginosa (15mm) except Staphylococcus aureus which was not inhibited by any of these 
antibiotics. On the other hand, all the isolates exhibited resistance to Amoxycillin while 
E. coli, N. gonorrhoeae, S. typhi, Klebsiella pneumoniae, P.mirabilis and P. aeruginosa were 
resistant to Chloramphenicol, Tetracycline, Cloxacillin, Erythromycin, Augmentin and 
Streptomycin. Conclusion: The plant’s parts were found to possess antibacterial activities. 
The ethanol and petroleum ether were the best solvents for their extraction. 
Keywords: Alstonia congensis; leaf extract; stem bark extract; microbial isolates; anti-
microbial activity. 
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1. Introduction  
The plant, Alstonia congensis, has been extensively used in ethnomedicine. It is commonly 
known as stool wood. It is an evergreen rainforest tree occuring in Southern Nigeria and 
extending to Democratic Republic of Congo, Ghana and Angola (Gosse et al.,1999). It 
belongs to the family Apocynaceae. In Nigeria, it is called “Egbu-ora” by the Igbos, called 
‘Ahun” by the Yorubas and “Ukhu” by the Edos’. In Ghana, the plant is known as 
“Onyame dua”, “Osen-nuru” or “Sinduro”where the plant’s medicinal value has been 
acknowledged for its different use in ethnomedicine (Neuwinger, 2002). Alstonia 
congensis is found in both wetland and non-wetland areas. Another species of Alstonia, A. 
boonei is also known to possess therapeutic properties. 
Studies have shown that Alstonia congensis has several medicinal properties both for 
human and other mammals (Feste et al., 2014). For instance, preliminary report have 
indicated that A.  congensis has anti-hyperglycemic, antioxidant and wound healing 
properties (Akinmoladun et al., 2007). Other properties include anti-plasmodial activities 
on Plasmodium berghei berghei infection in mice, analgesic effects on humans and it has 
also been used for the enhancement of rotarod period in albino mice and diuretic 
properties in male wistar rats. In humans, it has been used for the treatment of chronic 
diarrhoea and dysentery, fever, pain, intestinal disorders and as an antidote for 
strophanthus poison. It has also been used as anti-snake venom and as antidote for some 
arrows poisons, used for treatment of malaria, typhoid fever, gonorrhoea, yaws, asthma. 
It is believed to have anti-microbial properties (Sokeng et al., 2014).  
Different tissue extracts of Alstonia congensis have been severally reported to contain some 
essential phytochemicals. These phytochemicals have been discovered to contribute to 
the plant’s medicinal properties especially the anti-microbial effects (Momoh et al., 2014). 
In many parts of Africa, ethno-medicinal practitioners are known to have used extracts 
of Alstonia congensis parts for the treatment of various diseases including its use as anti-
bacterial agents. It has been found most effective on certain bacteria such as: Bacillus cereus, 
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Esche richia coli, Salmonella typhi, some species of Shigellaas well as Staphylococcus aureus 
(Victoria et al., 2000). Awe and Abatan (2007) reported that Alstonia congensis is good for 
the treatment of dysentery while Jones (2010) revealed that it is good for treating typhoid 
fever as well as asthma. It is used as an anti-malaria agent as well as an anti-hypertensive 
agent in Nigeria and some other African countries such as Angola and Congo (Awe et al., 
1990). However, little is known about the plant’s extract broad spectrum anti-microbial 
property.  
This research study was designed to evaluate the anti-microbial effects of the solvent 
extracts of Alstonia congensis (the plant’s leaf and stem bark) on some human pathogenic 
bacteria. Four different solvent extracts of Alstonia congensis were used. 
2. Materials and Methods  
2.1 Collection, Authentication and Processing of Plant Materials 
The plant, Alstonia congensis,was identified and authenticated at the Department of 
Botany, University of Ibadan, Nigeria. The plant’s leaf and stem bark were obtained from 
the University’s Botanical garden. The materials were washed thoroughly with distilled 
water, air-dried and each ground separately into fine powder for experimental use. 
2.2 Collection of Test Organisms 
Pure stock cultures of pathogenic bacterial isolates used were obtained from the Medical 
Microbiology Laboratory, University College Hospital, Ibadan, Nigeria. The bacterial 
cultures were maintained on Nutrient Agar (NA) slants and kept for 24 hours in a 
refrigerator before they were sub-cultured into freshly prepared Petri plate for nutrient 
replenishment. The organisms collected were: Escherichia coli, Neisseria gonorrhoeae, 
Salmonella typhi, Staphylococcus aureus, Proteus mirabilis, Pseudomonas aeruginosa and 
Klebsiella pneumoniae. 
2.2.1 Validity of test organisms 
The organisms were maintained in Nutrient Agar (NA) slants for 48 hours in a 
refrigerator at 4◦C before they were further sub-cultured into freshly prepared Petri plates 
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using streak plate method. Gram staining procedure and other relevant biochemical tests 
such as catalase, starch hydrolysis, oxidase, urease, indole and citrate were carried out on 
each of the isolates to establish the validity and viability of the test bacteria (Harrigan and 
McCane, 2003). 
2.3 Preparation of Plant Extracts 
According to the slightly modified method of Olayemi and Opaleye (2002), 
approximately 30 grams of the extract powder of each of Alstonia congensis plant parts 
(leaves and stem bark) were weighed and dissolved in 250ml of each of the four different 
solvents (hexane, ethanol, petroleum ether and sterile distilled water) in different 500ml 
beakers. Each beaker was then covered with aluminium foil and left for 24hrs but was 
stirred at 8hours interval using a glass rod stirrer. At the end of 24hours of soaking, the 
supernatant was filtered into 100ml beaker using Whatman No.1 filter paper. The extract 
was then used immediately and the remaining extract stored in the refrigerator for 
further use. 
2.4 Antimicrobial Susceptibility Test 
2.4.1 Agar well diffusion test 
The extracts were tested for anti-microbial activity using the agar well diffusion method. 
Wells were aseptically made on the nutrient agar plate using a sterile 8mm cork borer to 
make five different wells on each plate making sure that the fifth well that served as 
control was at the centre of the plate. The extracts were dispensed into the wells with the 
aid of a syringe and needle. This method allows the extract in the gel cavity to diffuse 
through the solid medium such that the growth of the inoculated microorganism was 
restricted by the efficacy of the extract’s constituent. This was manifested by a visible 
circular zone around the well containing the extract. The diameter of the observed clear 
zone was measured in millimeter using a transparent 30mm meter rule (Fawole and Osho, 
1998). 
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2.4.2 Inhibitory tests 
The test organism was streaked on the surface of the solidified nutrient agar plate using 
an inoculating wire loop. A sterile 8mm cork borer was used to make a uniform deep well 
into the agar gel. Serial dilutions of each of the extracts was further prepared by mixing 
10ml extracts with 5ml solvent, 10ml extracts with 10ml solvent, 10ml extracts with 15ml 
solvents and 10ml extracts with 20ml solvents to give concentrations of 80mg/ml, 
60mg/ml, 48mg/ml and 40mg/ml respectively. Each well was then filled with 1ml of 
extract prepared in different solvents. The petri plates were allowed to stand for 30 
minutes at room temperature to allow proper diffusion of extract. The control 
experiments were then set up using each of the solvents (without extract). The plates were 
incubated at 37◦C for 24 hours. The zone of inhibition around the bacterial colony was 
determined by direct measurement in millimeter (mm) scale (Harrigan and McCarne, 
2003). 
2.4.3 Determination of minimum inhibitory concentration (MIC) 
The Minimum Inhibitory Concentration was determined using the agar well diffusion 
technique. Minimum Inhibitory Concentration (MIC) is the lowest concentration of 
extract required to completely inhibit test organism after overnight incubation. It is also 
the lowest inhibitory concentration that can result to significant decrease in inoculums’ 
viability greater than 90% (Andrews, 2001). 
2.5 Antibiotic Susceptibility Test 
Antibiotic susceptibility testing was done with the use of antibiotic discs (gram positive 
and gram negative) by disc diffusion method (Bauer et al., 1996). Each of the stock 
pathogenic bacterial isolates from each of the nutrient agar slants was streaked on each 
of the nutrient agar plates. After this, the antibiotic discs were aseptically placed on each 
of the Petri plates using sterile forceps. The agar plates were then incubated at 37◦C for 24 
hours. After that, the plates were then examined for zones of inhibition. The zone of 
inhibition around each antibiotic disc was measured in millimeter using a transparent 
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metre ruler. Antibiotic susceptibility was depicted by the diameter of the zone of 
inhibition around each antibiotic disc.  
The antibiotic susceptibility patterns as shown by the zones of inhibition observed on the 
agar plates is referred to as an Antibiogram. 
3. Results 
 3.1 Inhibitory Test for Bacterial Isolates- Potency of Plant’s Parts Extracts 
Table 1. shows the potency of extracts of the leaf of Alstonia congensis on some human 
pathogenic bacteria. The leaf extract made with ethanol seemed highly effective on 
Escherichia coli (40mg/ml), Neisseria gonorrhoeae (60mg/ml), Salmonella typhi (60mg/ml), 
Staphylococcus aureus (60mg/ml), Pseudomonas aeruginosa (40mg/ml) and Klebsiella 
pneumoniae (48mg/ml) but seemed slightly effective on Proteus mirabilis (80mg/ml). 
Petroleum ether extract of the leaf of Alstonia congensis showed a very strong effect on six 
of the seven isolates which were: Escherichia coli (48mg/ml), Neisseria gonorrhoeae 
(40mg/ml), Staphylococcus aureus (40mg/ml), Salmonella typhi (40mg/ml), Pseudomonas 
aeruginosa (40mg/ml) and Klebsiella pneumoniae (48mg/ml). However, it showed little 
effect on Proteus mirabilis (80mg/ml). Hexane extract of the leaf had no effect on any of the 
microbial isolates which included: Escherichia coli, Neisseria gonorrhoeae, Staphylococcus 
aureus, Salmonella typhi, Proteus mirabilis, Pseudomonas aeruginosa and Klebsiella pneumoniae. 
The results of the potency of extracts of the stem bark of Alstonia congensis on the human 
pathogenic bacteria are presented in Table 2.  Hexane extract was highly effective on 
Escherichia coli (60mg/ml), Proteus mirabilis (60mg/ml) and Klebsiella pneumoniae (40mg/ml) 
only. It showed no effect on Neisseria gonorrhoeae, Staphylococcus aureus, Salmonella typhi 
and Pseudomonas aeruginosa. The ethanolic extract of the stem bark was found to be 
effective on Neisseria gonorrhoeae (40mg/ml), Staphylococcus aureus (48mg/ml), Salmonella 
typhi (40mg/ml), Proteus mirabilis (60mg/ml), Pseudomonas aeruginosa (40mg/ml) and 
Klebsiella pneumoniae (60mg/ml). It showed no observable effect on Escherichia coli. The 
petroleum ether extract seemed greatly effective on Escherichia coli (48mg/ml), 
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Staphylococcus aureus (40mg/ml), Salmonella typhi (40mg/ml), Proteus mirabilis (48mg/ml), 
Pseudomonas aeruginosa (60mg/ml) and Klebsiella pneumoniae (40mg/ml). It seemed 
ineffective on Neisseria gonorrhoeae. The aqueous extract of the stem bark showed slight 
effects on Neisseria gonorrhoeae, Staphylococcus aureus, Salmonella typhi, Proteus mirabilis, 
Pseudomonas aeruginosa and Klebsiella pneumoniae at MIC of 80mg/ml. It had no observable 
effect on Escherichia coli. 
3.2 Minimum Inhibitory Concentration (MIC) 
In Tables 3. and 4., the results of minimum inhibitory concentrations of the extracts of the 
leaf and stem bark of Alstonia congensis are shown. According to Andrews (2001), the 
Minimum Inhibitory Concentration (MIC) is the lowest concentration of extract required 
to completely inhibit test organism up to 24hours incubation or lowest concentration that 
can result to significant decrease in inoculums’ viability greater than 90%. 
 3.3 Minimum Bactericidal Concentration 
Minimum Bactericidal Concentration (MBC) according to French (2006) is an expression 
of Lethal Dosage (LD) of an extract. MBC, in technical sense, expresses the minimum 
concentration of an extract that would be potent enough to inhibit 99.9% of ±> 10mm 
diameter of clearance. 
3.4 Data Comparison 
3.4.1 Sensitivity of the isolates to standard antibiotics  
The potency of each of the antibiotics in the Standard Antibiotics Discs (SAD) on the 
bacterial isolates are presented in Tables 5. and 6. The diameter of the zone of inhibition 
revealed that the following antibiotics were potent on certain microbial isolates: 
Cotrimoxazole had effect on Staphylococcus aureus (30mm), Proteus mirabilis (15mm) and 
Pseudomonas aeruginosa (18mm) but had no effect on Escherichia coli, Neisseria gonorrhoeae, 
Salmonella typhi and Klebsiella pneumoniae. However, Nitrofurantoin had effect on 
Escherichia coli (15mm), Neisseria gonorrhoeae (18mm), Salmonella typhi (22mm) and Proteus 
mirabilis (13mm) but had no effect on Staphylococcus aureus, Klebsiella pneumoniae and 
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Pseudomonas aeruginosa. Gentamicin had effect on the bacterial isolates except Klebsiella 
pneumoniae while Nalidixic acid had effect on five of the isolates which were: Escherichia 
coli (22mm), Neisseria gonorrhoeae (22mm), Salmonella typhi (20mm), Klebsiella pneumoniae 
(10mm) and Pseudomonas aeruginosa (20mm). Two of the isolates exhibited resistance to 
Nalidixic acid. These were Staphylococcus aureus and Proteus mirabilis. 
Ofloxacin was effective on the bacterial isolates except Staphylococcus aureus. 
Chloramphenicol was ineffective on six of the bacterial isolates but was effective against 
Staphylococcus aureus (30mm). 
Tetracycline had effect on just three of the bacterial isolates and these were: Staphylococcus 
aureus (30mm), Klebsiella pneumoniae (3mm) and Proteus mirabilis (17mm). Four out of the 
seven isolates exhibited resistance to Tetracycline. These were: Escherichia coli, Neisseria 
gonorrhoeae, Salmonella typhi and Pseudomonas aeruginosa. The isolates except 
Staphylococcus aureus exhibited resistance to Cloxacillin, Erythromycin, Augmentin and 
Streptomycin. 
3.4.2 Comparison between the results of the solvent extracts of Alstonia congensis and 
those of standard antibiotic discs  
The ethanolic and petroleum ether extracts of the leaf and stem bark of Alstonia congensis 
had high inhibitory effect (30mm - 48mm zone of inhibition) on the bacterial isolates with 
MIC value of 40mg/ml for Neissseria gonorrhoeae, Staphylococcus aureus, Salmonella typhi, 
Pseudomonas aeruginosa, Klebsiella pneumoniae and MIC value of 48mg/ml for Escherichia 
coli and Proteus mirabilis. 
Cotrimoxazole inhibited Staphylococcus aureus (30mm zone of inhibition), Proteus mirabilis 
(15mm zone of inhibition), Pseudomonas aeruginosa (18mm zone of inhibition). 
Nitrofurantoin inhibited Escherichia coli (15mm zone of inhibition), Neisseria gonorrhoeae 
(18mm zone of inhibition), Salmonella typhi (22mm zone of inhibition) and Proteus mirabilis 
(13mm zone of inhibition). Gentamicin inhibited Staphylococcus aureus (30mm zone of 
inhibition), Escherichia coli (9mm zone of inhibition), Neisseria gonorrhoeae (13mm zone of 
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inhibition), Salmonella typhi (12mm zone of inhibition), Proteus mirabilis (13mm zone of 
inhibition) and Pseudomonas aeruginosa (15mm zone of inhibition). Nalidixic acid 
inhibited Escherichia coli and Neisseria gonorrhoeae (with 22mm zones of inhibition), 
Salmonella typhi and Pseudomonas aeruginosa (with 20mm zones of inhibition). Ofloxacin 
inhibited Escherichia coli (21mm zone of inhibition), Neisseria gonorrhoeae (25mm zone of 
inhibition), Salmonella typhi and Proteus mirabilis (30mm zones of inhibition), Pseudomonas 
aeruginosa (24mm zone of inhibition) and Klebsiella pneumoniae (22mm zone of inhibition). 
Comparison between the solvent extracts and the Standard Antibiotic Discs revealed that 
both were equally potent on Staphylococcus aureus, Escherichia coli, Neisseria gonorrhoeae, 
Salmonella typhi, Proteus mirabilis and Pseudomonas aeruginosa. However, Ofloxacin 
appeared to be a broader spectrum antibiotic compared to the others used for the analysis. 
This similarity in bacterial inhibition suggests the anti-microbial properties of the solvent 
extracts of Alstonia congensis. 
4.  Discussion 
Herbal medicine is readily available in many African countries and has been used by 
many different cultures throughout the world to treat illnesses and to assist bodily 
functions. Alstonia congensis as a medicinal plant has been used locally in many African 
countries for various therapeutic purposes (Precious et al., 2012). It is now a known fact 
that resistance to antibiotics has become a major problem to both developed and 
developing countries. The discovery that reasonably low concentrations of the crude 
extracts of parts of Alstonia congensis can be used to inhibit microbial growth is therefore 
of tremendous interest.  
Hexane extract of the stem bark of Alstonia congensis exhibited inhibitory effect on: 
Escherichia coli, Proteus mirabilis at 60mg/ml concentration and Klebsiella pneumoniae at 
40mg/ml. It was ineffective on Neisseria gonorrhoeae, Staphylococcus aureus, Salmonella typhi 
and Pseudomonas aeruginosa. These findings are in agreement with those of Mukherjee et 
al. (2012) who reported that the hexane extract of the stem bark was effective on E. coli, 
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Shigella dysenteriae, Proteus mirabilis and Serratia marcescens. Mukherjee et al. (2012) 
concluded that this may be as a result of the solubility of the active compounds of the 
stem bark in hexane. 
The ethanolic extract of the stem bark of Alstonia congensis was highly inhibitory on 
Neisseria gonorrhoeae, Salmonella typhi and Pseudomonas aeruginosa at 40mg/ml 
concentration, Staphylococcus aureus at 48mg/ml concentration, Proteus mirabilis and 
Klebsiella  pneumoniae at 60mg/ml concentration but ineffective on Escherichia coli. Igbinosa 
et al. (2009) reported that the ethanolic extract of the stem bark of Alstonia congensis 
exhibited higher anti-microbial activity than its aqueous extract or than its any other 
extract used on the Gram positive and Gram negative bacteria such as Escherichia coli, 
Bacillus subtilis, Pseudomonas aeruginosa, Staphylococcus aureus and Neisseria gonorrhoeae. 
The petroleum ether extract of the stem bark of Alstonia congensis in comparison with the 
other extracts exhibited the highest potency on the selected human pathogenic bacteria. 
The stem bark extract of Alstonia congensis obtained with petroleum ether was potent on 
Staphylococcus aureus, Salmonella typhi and Klebsiella pneumoniae at 40mg/ml concentration, 
Escherichia coli and Proteus mirabilis at 48mg/ml concentration and Pseudomonas aeruginosa 
at 60mg/ml concentration but however ineffective on Neisseria gonorrhoeae. This is 
contrary to the findings of Salawu et al. (2009), who reported that the stem bark of Alstonia 
congensis was freely soluble in water, less soluble in 96% alcohol, sparingly soluble in 
absolute alcohol and insoluble in petroleum ether when they researched on this plant’s 
extract’s  inhibition of some gram positive and gram negative bacteria.  
The petroleum ether extract of the leaves of Alstonia congensis showed very high potency 
on Neisseria gonorrhoeae, Staphylococcus aureus, Salmonella typhi, Proteus mirabilis and 
Pseudomonas aeruginosa and Klebsiella pneumoniae at 80mg/ml and at 120mg/ml 
concentrations. These results tally with the research findings of Raji et al. (1999), who 
reported that the anti-bacterial constituents of the plant were preferentially concentrated 
in the stem bark and leaves.  
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Hexane, petroleum ether and aqueous extracts of the leaves of Alstonia congensis showed 
zones of inhibition. These findings is in agreement with the research findings of Ojewole 
(2002) who reported that the leaves of Alstonia congensis, to an extent, have anti-bacterial 
activity on some gram positive and some gram negative bacteria using these same 
extractants.  
It was discovered in this research study that test bacterial isolates were more susceptible 
to ethanolic extracts than aqueous extracts. This is in agreement with the findings of 
Taiwo et al. (1998) who reported that the higher susceptibility of bacterial isolates to 
ethanolic extracts may be due to the high phytochemical extraction capability of ethanol. 
Koduru et al. (2006) demonstrated that ethanolic and petroleum ether extracts of the plant 
they studied had more inhibitory effects than the hexane and aqueous extracts. 
The inhibitory effects of hexane and aqueous extracts of medicinal plants have been 
reported by Salawu et al. (1992), Olusola and Saidu (1997), Raji et al. (2005) and Ebiloma 
et al. (2007). The findings of Odugbemi and Akinsulire (2012) also affirm that ethanol and 
petroleum ether are good solvents for the extraction of most plants of medical importance. 
The findings of this present experimental study show that both gram positive and gram 
negative bacteria are susceptible to the inhibitory actions of the solvent extracts of the 
leaves and stem bark of Alstonia congensis. In fact, the petroleum ether extracts of the 
leaves and stem bark of the plant were found to be most active on all the tested gram 
negative bacterial strains followed by the ethanolic extracts. This is similar to the findings 
of Akintobi et al. (2016) who worked on the phytochemical and anti-microbial evaluation 
of the extracts of some parts of Parkia biglobosa. 
The inhibitory effects of the ethanolic and petroleum ether extracts of the leaves and stem 
bark of Alstonia congensis on the bacterial isolates may be similar to those of Gentamicin, 
Nalidixic acid and Ofloxacin. These bacterial isolates include: Escherichia coli, Neisseria 
pneumoniae, Salmonella typhi, Proteus mirabilis and Pseudomonas aeruginosa. It could 
therefore be reasoned that the phytochemicals might be part of the active ingredients in 
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the extracts. This may be inferred from the findings and conclusions of Mukherjee et al. 
(2012) who worked on the phytochemical screening of the root and leaf extracts of 
Alstonia boonei. 
 4.1 Conclusion 
In-vitro, the extracts of the leaves and stem bark of Alstonia congensis using hexane, 
ethanol, petroleum ether and water (aqueous) were tested on human pathogenic bacteria: 
Escherichia coli, Neisseria gonorrhoeae, Salmonella typhi, Staphylococcus aureus, Proteus 
mirabilis, Pseudomonas aeruginosa and Klebsiella pneumonia.  The petroleum ether and 
ethanolic extracts of the leaves and stem bark of the plant were separately highly potent 
on Salmonella typhi while the stem bark extract was highly effective on Escherichia coli. 
This suggests the anti-microbial properties of the plant extracts. The results make us 
suggest that ethanol and petroleum ether were the best solvents of extraction for the 
leaves and stem bark of Alstonia congensis for anti-bacterial activity of the selected 
pathogenic human isolates. 
4.2 Recommendation 
Medicinal plants like Alstonia congensis whose properties have not been fully 
characterized should be further investigated for more information. If this policy is 
pursued, it would enable citizens of developing countries who cannot afford to purchase 
orthodox medicine have access to various plants of therapeutic components. Further 
studies should be carried out in the realm of pharmacy and medicine in order to isolate, 
characterize and purify the bioactive constituents of the Alstonia congensis with a view to 
determining the plant extracts’ spectrum of anti-microbial activity. This is with the view 
to adding to already established anti-microbial agents. By doing this, it may also be a new 
source of anti-microbial compounds that could be used to combat drug resistant bacteria 
which have become a global challenge. 
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Table 1: The diameter of zones of inhibition (mm) of the leaf extracts of Alstonia 
congensis for some human pathogenic bacteria 
 
Bacterial isolates Solvent for 
extraction 
120mg/ml 80mg/ml 60mg/ml 48mg/ml 40mg/ml Control 
Escherichia coli Hexane 
Ethanol 
Pet.ether 
Aqueous  
- 
31 
45 
12 
- 
25 
20 
11 
- 
18 
18 
- 
- 
9 
10 
- 
- 
4 
- 
- 
- 
07 
09 
- 
Neisseria 
gonorrhoeae 
Hexane 
Ethanol 
Pet.ether 
Aqueous 
- 
30 
48 
14 
- 
18 
28 
11 
- 
12 
21 
- 
- 
- 
13 
- 
- 
- 
10 
- 
- 
09 
06 
- 
Staphylococcus 
aureus 
Hexane 
Ethanol 
Pet.ether 
Aqueous 
- 
23 
43 
13 
- 
19 
37 
10 
- 
10 
29 
- 
- 
- 
21 
- 
- 
- 
17 
- 
- 
- 
08 
- 
Salmonella typhi Hexane 
Ethanol 
Pet.ether 
Aqueous 
- 
20 
44 
20 
- 
17 
30 
15 
- 
13 
23 
11 
- 
- 
15 
- 
- 
- 
12 
- 
- 
03 
04 
- 
Proteus Mirabilis Hexane 
Ethanol 
Pet.ether 
Aqueous 
- 
26 
25 
14 
- 
22 
18 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
06 
- 
Pseudomonas 
aeruginosa 
Hexane 
Ethanol 
Pet.ether 
Aqueous 
- 
20 
30 
15 
- 
16 
27 
- 
- 
13 
16 
- 
- 
10 
10 
- 
- 
09 
08 
- 
- 
02 
06 
- 
Klebsiella 
Pneumoniae 
Hexane 
Ethanol 
Pet.ether 
Aqueous 
- 
32 
32 
- 
- 
25 
27 
- 
- 
22 
18 
- 
- 
15 
09 
- 
- 
- 
- 
- 
- 
- 
07 
- 
Key: n = 3 (Each value is a mean value from triplicate raw data) 
- = resistant (negative) 
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Table 2: The diameter of zones of inhibition of the stem bark extracts of Alstonia 
congensis for some human pathogenic bacteria 
 
Bacterial isolates Solvent for 
extraction 
120mg/ml 80mg/ml 60mg/ml 48mg/ml 40mg/ml Control 
Escherichia coli Hexane 
Ethanol 
Pet.ether 
Aqueous  
41 
- 
44 
- 
38 
- 
40 
- 
34 
- 
37 
- 
- 
- 
30 
- 
- 
- 
- 
- 
13 
- 
25 
- 
Neisseria 
gonorrhoeae 
Hexane 
Ethanol 
Pet.ether 
Aqueous 
- 
28 
- 
05 
- 
23 
- 
- 
- 
20 
- 
- 
- 
18 
- 
- 
- 
13 
- 
- 
- 
- 
- 
- 
Staphylococcus 
aureus 
Hexane 
Ethanol 
Pet.ether 
Aqueous 
- 
25 
29 
08 
- 
23 
24 
02 
- 
20 
21 
- 
- 
07 
19 
- 
- 
- 
10 
- 
- 
15 
09 
- 
Salmonella typhi Hexane 
Ethanol 
Pet.ether 
Aqueous 
- 
18 
41 
08 
- 
16 
32 
02 
- 
10 
28 
- 
- 
08 
20 
- 
- 
04 
13 
- 
- 
- 
07 
- 
Proteus Mirabilis Hexane 
Ethanol 
Pet.ether 
Aqueous 
21 
29 
42 
11 
15 
23 
37 
05 
10 
18 
25 
- 
- 
- 
18 
- 
- 
- 
- 
- 
08 
- 
08 
- 
Pseudomonas 
aeruginosa 
Hexane 
Ethanol 
Pet.ether 
Aqueous 
- 
23 
25 
09 
- 
18 
22 
06 
- 
15 
16 
- 
- 
14 
- 
- 
- 
12 
- 
- 
- 
07 
10 
- 
Klebsiella 
Pneumoniae 
Hexane 
Ethanol 
Pet.ether 
Aqueous 
31 
23 
51 
14 
28 
14 
40 
- 
20 
13 
28 
- 
12 
- 
14 
- 
10 
- 
12 
- 
- 
03 
06 
- 
Key: n = 3 (Each value is a mean value from triplicate raw data) 
- = resistant (negative)  
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Table 3: The Minimum Inhibitory Concentration (MIC) of the leaf extracts of 
Alstonia congensis on some human pathogenic bacteria 
 
Bacterial isolates Solvent for 
extraction 
120mg/ml 80mg/ml 60mg/ml 48mg/ml 40mg/ml Control 
Escherichia coli Hexane 
Ethanol 
Pet.ether 
Aqueous  
- 
31 
45 
12 
- 
25 
20 
11 
- 
18 
18 
- 
- 
9 
10 
- 
- 
4 
- 
- 
- 
07 
09 
- 
Neisseria 
gonorrhoeae 
Hexane 
Ethanol 
Pet.ether 
Aqueous 
- 
30 
48 
14 
- 
18 
28 
11 
- 
12 
21 
- 
- 
- 
13 
- 
- 
- 
10 
- 
- 
09 
06 
- 
Staphylococcus 
aureus 
Hexane 
Ethanol 
Pet.ether 
Aqueous 
- 
23 
43 
13 
- 
19 
37 
10 
- 
10 
29 
- 
- 
- 
21 
- 
- 
- 
17 
- 
- 
- 
08 
- 
Salmonella typhi Hexane 
Ethanol 
Pet.ether 
Aqueous 
- 
20 
44 
20 
- 
17 
30 
15 
- 
13 
23 
11 
- 
- 
15 
- 
- 
- 
12 
- 
- 
03 
04 
- 
Proteus Mirabilis Hexane 
Ethanol 
Pet.ether 
Aqueous 
- 
26 
25 
14 
- 
22 
18 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
06 
- 
Pseudomonas 
aeruginosa 
Hexane 
Ethanol 
Pet.ether 
Aqueous 
- 
20 
30 
15 
- 
16 
27 
- 
- 
13 
16 
- 
- 
10 
10 
- 
- 
09 
08 
- 
- 
02 
06 
- 
Klebsiella 
Pneumoniae 
Hexane 
Ethanol 
Pet.ether 
Aqueous 
- 
32 
32 
- 
- 
25 
27 
- 
- 
22 
18 
- 
- 
15 
09 
- 
- 
- 
- 
- 
- 
- 
07 
- 
Key: n = 3 (Each value is a mean value from triplicate raw data) 
- = resistant (negative) 
Each value in the figure represents the zone of inhibition 
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Table 4: The Minimum Inhibitory Concentration (MIC) of the stem bark extracts of  
   Alstonia congensis on some human pathogenic bacteria 
 
Bacterial isolates Solvent for 
extraction 
120mg/ml 80mg/ml 60mg/ml 48mg/ml 40mg/ml Control 
Escherichia coli Hexane 
Ethanol 
Pet.ether 
Aqueous  
41 
- 
44 
- 
38 
- 
40 
- 
34 
- 
37 
- 
- 
- 
30 
- 
- 
- 
- 
- 
13 
- 
25 
- 
Neisseria 
gonorrhoeae 
Hexane 
Ethanol 
Pet.ether 
Aqueous 
- 
28 
- 
10 
- 
23 
- 
05 
- 
20 
- 
- 
- 
18 
- 
- 
- 
13 
- 
- 
- 
- 
- 
- 
Staphylococcus 
aureus 
Hexane 
Ethanol 
Pet.ether 
Aqueous 
- 
25 
29 
08 
- 
23 
24 
02 
- 
20 
21 
- 
- 
07 
19 
- 
- 
- 
10 
- 
- 
15 
09 
- 
Salmonella typhi Hexane 
Ethanol 
Pet.ether 
Aqueous 
- 
18 
41 
08 
- 
16 
32 
02 
- 
10 
28 
- 
- 
08 
20 
- 
- 
04 
13 
- 
- 
- 
07 
- 
Proteus Mirabilis Hexane 
Ethanol 
Pet.ether 
Aqueous 
21 
29 
42 
11 
15 
23 
37 
05 
10 
18 
25 
- 
- 
- 
18 
- 
- 
- 
- 
- 
08 
- 
08 
- 
Pseudomonas 
aeruginosa 
Hexane 
Ethanol 
Pet.ether 
Aqueous 
- 
23 
25 
09 
- 
18 
22 
06 
- 
15 
16 
- 
- 
14 
- 
- 
- 
12 
- 
- 
- 
07 
10 
- 
Klebsiella 
Pneumoniae 
Hexane 
Ethanol 
Pet.ether 
Aqueous 
31 
23 
51 
14 
28 
14 
40 
- 
20 
13 
28 
- 
12 
- 
14 
- 
10 
- 
12 
- 
- 
03 
06 
- 
 
Key:  n = 3 (Each value is a mean value from triplicate raw data) 
- = resistant (negative)  
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Table 5: The diameter of zones of inhibition (mm) of gram positive bacterial isolate 
using Standard Antibiotics Discs (SAD) 
 
Antibiotics Disc Code Disc Concentration 
(ug/l) 
Staphylococcus aureus 
Amoxycillin AMX 25 - 
Cotrimoxadole COT 25 30mm 
Nitrofurantoin NIT 300 - 
Gentamicin GEN 10 30mm 
Nalidixic Acid NAL 30 - 
Ofloxacin OFL 30 - 
Chloramphenicol CHL 10 30mm 
Tetracycline TET 30 30mm 
Cloxacillin CXC 5 30mm 
Erythromycin ERY 5 30mm 
Augmentin AUG 30 30mm 
Streptomycin  STR 10 30mm 
 
Key:  - = resistant (negative)   
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Table 6: The diameter of zones of inhibition (mm) of gram negative bacterial isolates using Standard Antibiotics Discs 
(SAD) 
Antibiotics Disc 
Code 
Disc Concentration 
(ug/l) 
E.coli  N.gonorrhoeae S.typhi P.mirabilis P.aeruginosa K.pneumoniae 
Amoxycillin AMX 25 - - - - - - 
Cotrimoxadole COT 25 - - - 15mm 18mm - 
Nitrofurantoin NIT 300 15mm 18mm 22mm 13mm - - 
Gentamicin GEN 10 9mm 13mm 12mm 13mm 15mm - 
Nalidixic Acid NAL 30 22mm 22mm 20mm - 20mm 10mm 
Ofloxacin OFL 30 21mm 25mm 30mm 30mm 24mm 22mm 
Chloramphenicol CHL 10 - - - - - - 
Tetracycline TET 30 - - - 17mm - 3mm 
Cloxacillin CXC 5 - - - - - - 
Erythromycin ERY 5 - - - - - - 
Augmentin AUG 30 - - - - - - 
Streptomycin STR 10 - - - - - - 
 Key: - = resistant (negative)   
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